Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Recurrent Small Hepatocellular Carcinoma: A Randomized, Open-Label, Controlled Trial
SBRT achieved better LPFS than that of RFA in patients with single recurrent HCC ≤5 cm, especially in HCC ≤2 cm, whereas PFS, OS, and safety were comparable between the two treatments.
Authors
- Dandan Hu (ORCID: https://orcid.org/0000-0001-7905-8536)
- Mian Xi (ORCID: https://orcid.org/0000-0002-8088-0970)
- Yizhen Fu (ORCID: https://orcid.org/0000-0003-1919-7176)
- Yaojun Zhang (ORCID: https://orcid.org/0000-0002-9752-4729)
- Li Xu (ORCID: https://orcid.org/0000-0003-4405-1048)
- Baoqing Chen (ORCID: https://orcid.org/0000-0001-9807-7425)
- Aiping Fang (ORCID: https://orcid.org/0000-0001-9139-3898)
- Zhoutian Yang (ORCID: https://orcid.org/0009-0007-0261-8479)
- Qiaoqiao Li (ORCID: https://orcid.org/0000-0002-6299-4966)
- Shiliang Liu (ORCID: https://orcid.org/0000-0001-5830-5171)
- Jingxian Shen
- Jing Zhao (ORCID: https://orcid.org/0000-0002-1557-9022)
- Minshan Chen (ORCID: https://orcid.org/0000-0002-6116-5015)
- Li Hu (ORCID: https://orcid.org/0000-0001-9588-9639)
- Zhongguo Zhou
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
- State Key Laboratory of Oncology in South China
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1200/jco-24-01532
- Citations
- 42
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 15.52